Health Reform Job One: Stop the Gouging! | Part 2
By BOB HERTZ
We Need Legal Assaults On The Greediest Providers!
When a patient is hospitalized, or diagnosed with a deadly disease, they often have no choice about the cost of their treatment.
They are legally helpless, and vulnerable to price gouging.
We need more legal protection of patients. In some cases we need price controls.
Next in this three-part series, I discuss how we could challenge Big Pharma by lessening regulation of generic drugs, having the government take over production and establishing price review boards.
Assault Phase Three – Challenge Big Pharma
Step One – Less Regulation of...
Source: The Health Care Blog - July 25, 2019 Category: Consumer Health News Authors: Christina Liu Tags: Uncategorized Source Type: blogs
Making the Revolving Door Great Again: Recent FDA Commissioner Dr Scott Gottlieb Joins the Pfizer Board of Directors
(Source: Health Care Renewal)
Source: Health Care Renewal - July 7, 2019 Category: Health Management Tags: Donald Trump FDA health care corruption Pfizer revolving doors Source Type: blogs
Do Companies Have a Duty to Pursue Clinical Trials: Enbrel and the Suggestion of Alzheimer ’s
by Craig Klugman, Ph.D.
In 1983, NBC broadcast an alien invasion limited series calledV. In one episode, as the U.S. devolves into a tyranny, the military invades scientific labs and finds—inside the filing cabinets (it was pre-computer days)—cures for cancer and other diseases that were simply never released because companies made more money treating disease than curing it. From that 36 year old television image has come a modern reality—Pfizer may have a drug that improves the chances of preventing Alzheimer’s Disease, but they won’t pay for the clinical testing.… (Source: blog.bioethics.net)
Source: blog.bioethics.net - June 7, 2019 Category: Medical Ethics Authors: Craig Klugman Tags: Clinical Trials & Studies Featured Posts Human Subjects Research & IRBs Research Ethics Source Type: blogs
Fight Aging! Newsletter, April 1st 2019
In conclusion, long-term aerobic exercise appears to attenuate the decline in endothelial vascular function, a benefit which is maintained during chronological aging. However, currently there is not enough evidence to suggest that exercise interventions improve vascular function in previously sedentary healthy older adults.
Hijacking the Proteasome to Dispose of Unwanted Molecules in Age-Related Disease
https://www.fightaging.org/archives/2019/03/hijacking-the-proteasome-to-dispose-of-unwanted-molecules-in-age-related-disease/
Cells are equipped with a protein disposal system in the form of the proteas...
Source: Fight Aging! - March 31, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Despite Public Protestations of of Bipartisanship, Many CEOs of the Largest US Health Care Corporations Appear Partisan, and Mainly Republican
(Source: Health Care Renewal)
Source: Health Care Renewal - March 28, 2019 Category: Health Management Tags: Abbott Amgen Bristol-Myers-Squibb conflicts of interest CVS deception Donald Trump Eli Lilly Gilead Merck mission-hostile management Pfizer Source Type: blogs
The Transparency International 2018 Corporate Political Engagement Index- Pharma Appears All Too Comfortable with the Revolving Door and Making Opaque Political Contributions
(Source: Health Care Renewal)
Source: Health Care Renewal - March 21, 2019 Category: Health Management Tags: AstraZeneca conflicts of interest dark money deception GlaxoSmithKline Johnson and Johnson Novartis Pfizer revolving doors Roche Shire Source Type: blogs
Fight Aging! Newsletter, March 11th 2019
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more.
This content is...
Source: Fight Aging! - March 10, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Video of Investor Jim Mellon Presenting at Abundance 360 Summit 2019
Jim Mellon's Juvenescence venture is at present one of the few major venture organizations focused on approaches to treat aging as a medical condition. Mellon and his colleagues outlined their take on the field in a 2017 book, also called Juvenescence. We are fortunate in that he is among the first few high net worth individuals to both agree with the SENS philosophy of damage repair, and then, much more importantly, follow through in action as well as word. He is not just seeing a massive market opportunity in treating aging, though that is certainly there, but is doing this because he wishes to achieve the goal of radica...
Source: Fight Aging! - March 4, 2019 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs
SRNT Under Fire for Accepting Sponsorship Money from E-Cigarette Company for Annual Meeting
Controversy is brewing in San Francisco this week as it was revealed that the Society for Research on Nicotine and Tobacco (SRNT) accepted money from an e-cigarette company to sponsor its annual meeting which is being held this week.It was reported this morning that SRNT accepted funding from GreenSmokeKloud, an e-liquid distributor whose products are competing with nicotine replacement therapy and Chantix for a share of the smoking cessation market.Critics pointed out that sponsorship of the conference by GreenSmokeKloud presents a severe conflict of interest because its products are being used for smoking cessation and t...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - February 21, 2019 Category: Addiction Source Type: blogs
Saying No to the Drug Crisis
By BRIAN KLEPPER
In a recent essay, VIVIO Health’s CEO Pramod John guides us through four sensible drug policy changes and supporting rationales that could make drug pricing much fairer. Reading through it, one is struck by the magnitude of the drug manufacturing industry’s influence over policy, profoundly benefiting that sector at the deep expense of American purchasers. As Mr. John points out, the U.S. has the world’s only unregulated market for drug pricing. We have created a safe harbor provision that allows and protects unnecessary intermediaries like pharmacy benefit managers. We have created mechanisms that u...
Source: The Health Care Blog - November 27, 2018 Category: Consumer Health News Authors: matthew holt Tags: Pharmaceuticals Politics Brian Klepper drug prices Pfizer Source Type: blogs
How to become a diabetic
It’s so easy, anyone can do it!
Becoming a type 2 diabetic and proudly having to finger stick your way to blood sugar control is patriotic, as it builds revenues for Big Pharma and the healthcare industry. What better way to support your country than to help successful industries grow larger, increase shareholder value, and increase the salary and perks for hard working executives?
So if you want to join the growing ranks of people who are becoming diabetic, now the largest epidemic of chronic disease ever witnessed in the history of the world, here’s what you do:
Cut your fat intake — Because it leaves you ...
Source: Wheat Belly Blog - October 23, 2018 Category: Cardiology Authors: Dr. Davis Tags: News & Updates diabetes gluten gluten-free grain-free grains wheat belly Source Type: blogs
How Could Genomics Bring Precision Medicine To Healthcare?
By 2025, between 100 million and 2 billion human genomes will have been sequenced, researchers said. What do medical research, companies or governments do with such an incredible amount of data? How could genomics bring DNA-based targeted treatments, personalized drugs, and individualized clinical methods, in other words, precision medicine to healthcare?
Does disease categorize people?
In the previous centuries, healthcare systems focused mainly on working out generalized solutions for treating ill people in as high numbers as possible. If cough syrup was good for the majority of the coughing masses and only two people ha...
Source: The Medical Futurist - October 20, 2018 Category: Information Technology Authors: nora Tags: Biotechnology Business Genomics Healthcare Policy Medical Professionals Policy Makers Researchers future Gene genes Genetic testing genetics Genome genome sequencing Innovation personal genomics precision medicine predict Source Type: blogs
Pharma's Dark Money: Touting Corporate Responsibility and Non-Partisanship, But Using Dark Money to Promote Self-Serving Policies and Partisan Causes
DiscussionSo in three cases, health care corporations, and/or their trade associations, made significant financial contributions todark money organizations, thus avoiding reporting of such fund transfers. In two cases, these fund transfers went to organizations with clearly partisan, right-wing, pro-Republican and/or pro-Trump agendas. Yet the corporations and their trade association had publicly committed themselves to social responsibility, putting patients and health care ahead of all other concerns, and had never advertised themselves as partisan, explicitly politically conservative, and/or Republican.This ...
Source: Health Care Renewal - September 30, 2018 Category: Health Management Tags: Amgen Biogen Idec dark money deception health care prices Johnson and Johnson PhRMA ppaca propaganda stealth health policy advocacy stealth lobbying You heard it here first Source Type: blogs
Fake Reform Foisted on Us by Those who Benefit Most from the Current Dysfunction
ConclusionGiridharadas suggested inan interview in New York Magazine,What all that does is create this moral glow. And under the haze created by that glow, they ’re able to create a probable monopoly that has harmed the most sacred thing in America, which is our electoral process, while gutting the other most sacred thing in America, our free press. And they do itunder the cover of changing the world.Unfortunately, he apparently has not come up with what to do about this problem. The best conclusion I can reach derives from the end of areview of his book by Joseph Stiglitz in the New York Times,Democracy and high l...
Source: Health Care Renewal - September 5, 2018 Category: Health Management Tags: conflicts of interest Gates Foundation health care foundations health care reform Johnson and Johnson Robert Wood Johnson Foundation Source Type: blogs
Fight Aging! Newsletter, September 3rd 2018
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more.
This content is...
Source: Fight Aging! - September 2, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
